An open study of aripiprazole and escitalopram for psychotic major depressive disorder. cdc.gov/nchs/products/databriefs/db377.htm Antidepressant use among adults: United States, 2015-2018. Aripiprazole augmentation in major depressive disorder: A double-blind, placebo-controlled study in patients with inadequate response to antidepressants. fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/atypical-antipsychotic-drugs-information
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |